Literature DB >> 10334313

An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.

P Faure1, E Rossini, N Wiernsperger, M J Richard, A Favier, S Halimi.   

Abstract

Recently there has been growing interest in the effects of antioxidants on insulin activity. In the present study, we investigated the effect of metformin on free radical activity and insulin sensitivity in high fructose-fed rats, a diet that leads to insulin resistance. The animals were divided into four groups (n = 16 per group; experiment duration = 6 weeks): the control (C) group received a standard diet; the control metformin (CM) group was fed a control diet and received metformin (200 mg x kg(-1) x day(-1) in water); the fructose control (FT) group was fed a diet in which fructose composed 56.8% of the total carbohydrates; and the fructose metformin (FM) group received high-fructose diet and metformin (200 mg x kg(-1) x day(-1) in water). The glucose clamp technique was used to determine insulin sensitivity in eight animals per group. Metabolic and oxidative stress parameters were measured in the remaining rats. In the FT rats, insulin resistance, lower red cell CuZn superoxide dismutase activity and lower blood reduced glutathione were observed. Metformin treatment improved both the insulin activity and the antioxidant defense system. In the CM group, metformin had no effect on metabolic parameters, but improved red cell antioxidant enzyme activities and the blood GSH level, which suggests that it has an antioxidant activity independent of its effect on insulin activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334313     DOI: 10.2337/diabetes.48.2.353

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  33 in total

1.  Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Authors:  Pascale Perret; Lotfi Slimani; Arnaud Briat; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

2.  Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats.

Authors:  Sandrine Morel; Corinne Berthonneche; Stéphane Tanguy; Marie-Claire Toufektsian; Pascale Perret; Catherine Ghezzi; Joël de Leiris; François Boucher
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.

Authors:  Melissa A Linden; Kristi T Lopez; Justin A Fletcher; E Matthew Morris; Grace M Meers; Sameer Siddique; M Harold Laughlin; James R Sowers; John P Thyfault; Jamal A Ibdah; R Scott Rector
Journal:  Appl Physiol Nutr Metab       Date:  2015-06-24       Impact factor: 2.665

4.  Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid.

Authors:  Bethany P Cummings; Kimber L Stanhope; James L Graham; Joseph L Evans; Denis G Baskin; Steven C Griffen; Peter J Havel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

5.  Red Blood Cell Susceptibility to Pneumolysin: CORRELATION WITH MEMBRANE BIOCHEMICAL AND PHYSICAL PROPERTIES.

Authors:  Monika Bokori-Brown; Peter G Petrov; Mawya A Khafaji; Muhammad K Mughal; Claire E Naylor; Angela C Shore; Kim M Gooding; Francesco Casanova; Tim J Mitchell; Richard W Titball; C Peter Winlove
Journal:  J Biol Chem       Date:  2016-03-16       Impact factor: 5.157

6.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

Review 7.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

8.  Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06       Impact factor: 2.890

9.  Abnormalities in carbohydrate and lipid metabolisms in high-fructose dietfed insulin-resistant rats: amelioration by Catharanthus roseus treatments.

Authors:  Karuna Rasineni; Ramesh Bellamkonda; Sreenivasa Reddy Singareddy; Saralakumari Desireddy
Journal:  J Physiol Biochem       Date:  2013-01-22       Impact factor: 4.158

Review 10.  The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Authors:  Linda T Tran; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-06-18       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.